Annual Total Debt
$177.02 M
-$2.06 M-1.15%
December 31, 2023
Summary
- As of February 8, 2025, KPTI annual total debt is $177.02 million, with the most recent change of -$2.06 million (-1.15%) on December 31, 2023.
- During the last 3 years, KPTI annual total debt has risen by +$45.89 million (+34.99%).
- KPTI annual total debt is now -1.97% below its all-time high of $180.58 million, reached on December 31, 2021.
Performance
KPTI Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$194.26 M
-$1.37 M-0.70%
September 30, 2024
Summary
- As of February 8, 2025, KPTI quarterly total debt is $194.26 million, with the most recent change of -$1.37 million (-0.70%) on September 30, 2024.
- Over the past year, KPTI quarterly total debt has dropped by -$1.37 million (-0.70%).
- KPTI quarterly total debt is now -0.70% below its all-time high of $195.63 million, reached on June 30, 2024.
Performance
KPTI Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
KPTI Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | -0.7% |
| 3 y3 years | +35.0% | +7.4% |
| 5 y5 years | +72.4% | +57.7% |
KPTI Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.0% | at low | -0.7% | +10.1% |
| 5 y | 5-year | -2.0% | +42.0% | -0.7% | +55.8% |
| alltime | all time | -2.0% | -100.0% | -0.7% | -100.0% |
Karyopharm Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $194.26 M(-0.7%) |
| Jun 2024 | - | $195.63 M(+10.9%) |
| Mar 2024 | - | $176.44 M(-0.3%) |
| Dec 2023 | $177.02 M(-1.1%) | $177.02 M(-0.3%) |
| Sep 2023 | - | $177.56 M(-0.3%) |
| Jun 2023 | - | $178.08 M(-0.3%) |
| Mar 2023 | - | $178.59 M(-0.3%) |
| Dec 2022 | $179.07 M(-0.8%) | $179.07 M(-0.3%) |
| Sep 2022 | - | $179.53 M(-0.2%) |
| Jun 2022 | - | $179.89 M(-0.2%) |
| Mar 2022 | - | $180.24 M(-0.2%) |
| Dec 2021 | $180.58 M(+37.7%) | $180.58 M(-0.2%) |
| Sep 2021 | - | $180.89 M(-0.2%) |
| Jun 2021 | - | $181.18 M(-0.2%) |
| Mar 2021 | - | $181.45 M(+38.4%) |
| Dec 2020 | $131.13 M(+5.2%) | $131.13 M(+1.3%) |
| Sep 2020 | - | $129.45 M(+1.3%) |
| Jun 2020 | - | $127.83 M(+1.3%) |
| Mar 2020 | - | $126.23 M(+1.2%) |
| Dec 2019 | $124.70 M(+21.5%) | $124.70 M(+1.2%) |
| Sep 2019 | - | $123.19 M(+1.2%) |
| Jun 2019 | - | $121.73 M(+1.3%) |
| Mar 2019 | - | $120.20 M(+17.1%) |
| Dec 2018 | $102.66 M | $102.66 M(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00 |
| Dec 2011 | $0.00 | - |
FAQ
- What is Karyopharm Therapeutics annual total debt?
- What is the all time high annual total debt for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual total debt year-on-year change?
- What is Karyopharm Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics quarterly total debt year-on-year change?
What is Karyopharm Therapeutics annual total debt?
The current annual total debt of KPTI is $177.02 M
What is the all time high annual total debt for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual total debt is $180.58 M
What is Karyopharm Therapeutics annual total debt year-on-year change?
Over the past year, KPTI annual total debt has changed by -$2.06 M (-1.15%)
What is Karyopharm Therapeutics quarterly total debt?
The current quarterly total debt of KPTI is $194.26 M
What is the all time high quarterly total debt for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly total debt is $195.63 M
What is Karyopharm Therapeutics quarterly total debt year-on-year change?
Over the past year, KPTI quarterly total debt has changed by -$1.37 M (-0.70%)